Skip to content

Need to access your results? Sign in
Create an account
Support

Providers
Patients
- Research Program
- Create Account
- Get Results
- FAQs
- Submit Request
- Diagnostics
- Resources
- FAQs
- Submit Request
Health Systems
- Diagnostic Testing
- Research
Press Releases
The Helix Research Network Adds Three New Health System Members, Transforming Clinical Genomics for Community Benefit
Read More
Life Sciences
Press Releases
Helix Partners with Komodo Health, Combining Helix's Clinico-Genomic Datasets with Komodo's Healthcare Map® for Clinical & Research Impact
Read More
Resources
- Media Library
- Webinars
- Videos
- Podcasts
- News & Press Releases
- In the news
- Press Releases
View All Resources
Videos
Partner Perspectives with Sanford Health
Watch Now
View All Resources
Company

Home
resources

Discover How Helix is Changing the World of Healthcare

Resources Hub

Get in touch

Weaving Genomics into the Fabric of Healthcare

Contact us:

Customer Support: (844) 211 2070 Monday - Friday: 6 AM – 6 PM (Pacific)

© 2016-2025 Helix, Inc. All rights reserved.

Helix, the Helix logo, Exome+, and Sequence Once, Query Often are trademarks of Helix, Inc.

Resources

Blog
Research
All Resources

Who we serve

Health Systems
Life Sciences
Public Health

Company

About Us
News
Press Releases
Careers

Contact Us

Partnerships
Participant Support

Participant Support

Contact Support
Help Center
Privacy & Policy Highlights
Privacy Requests

Privacy Policy
Terms of Service
Notice of Privacy Practices
Platform Consent
Accessibility
Privacy Settings

CLIA #05D2117342
CAP #9382893

The Latest Content From Helix

Recent Blog Posts

View All Blog Posts

Population Genomics: Personalizing Genetic Breast Cancer Screening

Unraveling the Power of Germline Clinico-Genomic Data: A Game Changer in Pharma's Drug Development Lifecycle

Preventable hospitalizations with increased oral SARS-CoV-2 antiviral treatment

What You Need to Know About the Newly Updated ASCO-SSO Guidelines

Recent Press Releases

View All Press Releases

Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development

Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward

Helix Launches World's Largest Clinico-Genomic Cohort of GLP-1 Agonist Treated Patients

February 3, 2025

Recent Videos

View All Videos

Partner Perspectives with Nebraska Medicine

Genetic Insights Project helps Nebraskans take charge of their health

Partner Perspectives with MUSC - Update

Revolutionizing Healthcare: In Our DNA SC

Partner Perspectives with Renown Health - Update

The Healthy Nevada Project - update 2023

Recent Published Research

View All Published Research

1

Published Research

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

2

Published Research

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

3

Published Research

Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia

4

Published Research

Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes

November 21, 2024

5

Published Research

Helix Debuts Novel Precision Effectiveness Model That Predicts 12-Month Weight Loss Response of Semaglutide in Diverse Populations

November 13, 2024

Recent Whitepapers

View All Whitepapers

Performance and Applications of Helix Exome+^® Assay

October 7, 2024

White Paper: Semaglutide and Weight Management

Technical Briefing 6: JN.1

January 3, 2024

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

October 11, 2023

Dr. James Lu Interview on New COVID-19 variants discovered in the U.S.

News

Jan 15, 2021

Dr. James Lu Interview on New COVID-19 variants discovered in the U.S.

Critical Mention

Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure

News

Jan 15, 2021

Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure

Business Wire

Helix Obtains FDA Authorization for Exome Sequencing Platform, Alzheimer's Disease Risk Test

News

Jan 11, 2021

Helix Obtains FDA Authorization for Exome Sequencing Platform, Alzheimer's Disease Risk Test

GenomeWeb

Helix Laboratory Platform Granted the First and Only FDA Authorization for a Whole Exome Sequencing Platform

Press Releases

Jan 11, 2021

Helix Laboratory Platform Granted the First and Only FDA Authorization for a Whole Exome Sequencing Platform

Update on the Helix, Illumina surveillance program: B.1.1.7 variant of SARS-CoV-2, first identified in the UK, spreads further into the US

Blog

Jan 11, 2021

Update on the Helix, Illumina surveillance program: B.1.1.7 variant of SARS-CoV-2, first identified in the UK, spreads further into the US

SARS-CoV-2 UK variant (B.1.1.7) in the US: Four cases identified in Florida and California

Blog

Dec 31, 2020

SARS-CoV-2 UK variant (B.1.1.7) in the US: Four cases identified in Florida and California

Is the new SARS-CoV-2 UK variant (B.1.1.7) already in the US? Maybe.

Blog

Dec 23, 2020

Is the new SARS-CoV-2 UK variant (B.1.1.7) already in the US? Maybe.

S gene dropout patterns in SARS-CoV-2 tests suggest spread of the H69del/V70del mutation in the US

Research

Dec 20, 2020

S gene dropout patterns in SARS-CoV-2 tests suggest spread of the H69del/V70del mutation in the US

MEDRXIV

5 ways Helix’s research community has advanced science in 2020

Blog

Dec 17, 2020

5 ways Helix’s research community has advanced science in 2020

Page 28